NCT01068717 - Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Saxagliptin, 2.5 mg + Metformin, 500 mg (fasted state)

Tablets, oral, 2.5-mg saxagliptin and 500-mg metformin, once daily, 1 week

DRUG

Saxagliptin, 2.5 mg /Metformin, 500 mg FDC (fasted state)

Tablets, oral, 2.5-mg saxagliptin/500-mg metformin fixed-dose combination (FDC), once daily, 1 week

DRUG

Saxagliptin, 2.5 mg + Metformin, 500 mg (fed state)

Tablets, oral, 2.5-mg saxagliptin and 500-mg metformin, once daily, 1 week

DRUG

Saxagliptin, 2.5 mg /Metformin, 500 mg FDC (fed state)

Tablets, oral, 2.5-mg saxagliptin and 500-mg metformin FDC, once daily, 1 week

Trial Locations (1)

Ppd Development, Lp, Austin